XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,607,998 | -11.8% | 3,003,747 | -0.6% | 0.76% | +29.5% |
| Q2 2023 | $116,349,734 | +7.8% | 3,022,071 | +0.2% | 0.59% | -16.3% |
| Q1 2023 | $107,971,916 | -10.1% | 3,016,818 | -1.0% | 0.70% | -26.8% |
| Q4 2022 | $120,098,812 | +24.9% | 3,045,874 | +14.4% | 0.96% | +56.4% |
| Q3 2022 | $96,124,000 | +24.4% | 2,662,722 | +4.8% | 0.61% | +34.8% |
| Q2 2022 | $77,269,000 | +15.4% | 2,540,059 | +16.0% | 0.45% | +50.3% |
| Q1 2022 | $66,950,000 | +27.0% | 2,190,059 | +29.7% | 0.30% | +52.5% |
| Q4 2021 | $52,734,000 | – | 1,688,044 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |